statistiche ricercatore

LISSONI, ANDREA ALBERTO

Distribuzione geografica

Continente	#
NA - Nord America	8076
EU - Europa	2421
AS - Asia	632
Continente sconosciuto - Info sul continente non disponibili	11
AF - Africa	4
SA - Sud America	4
OC - Oceania	1
Totale	11149

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	7914
SE - Svezia	481
CN - Cina	480
UA - Ucraina	478
IT - Italia	413
DE - Germania	373
CA - Canada	162
GB - Regno Unito	136
IE - Irlanda	115
AT - Austria	108
FI - Finlandia	100
VN - Vietnam	75
FR - Francia	62
DK - Danimarca	43
RU - Federazione Russa	37
NL - Olanda	27
BE - Belgio	22
TR - Turchia	22
IN - India	18
JP - Giappone	11
EU - Europa	9
IR - Iran	8
HK - Hong Kong	7
PL - Polonia	7
KR - Corea	6
RO - Romania	5
ES - Italia	4
BR - Brasile	3
CH - Svizzera	3
RS - Serbia	3
TW - Taiwan	3
A2 - ???statistics.table.value.countryCode.A2???	2
BG - Bulgaria	2
SC - Seychelles	2
ZA - Sudafrica	2
AU - Australia	1
CZ - Repubblica Ceca	1
EC - Ecuador	1
IL - Israele	1
MK - Macedonia	1
SG - Singapore	1
Totale	11149

Salva come PNG Salva come JPEG

Città	#
Ann Arbor	1842
Woodbridge	1187
Fairfield	673
Houston	663
Jacksonville	519
Chandler	414
Wilmington	398
Dearborn	335
Ashburn	306
Frankfurt am Main	286
Seattle	286
Cambridge	254
Princeton	214
Dublin	110
Vienna	108
Altamura	104
Nanjing	104
Lawrence	102
Lachine	91
Milan	79
Beijing	66
Fremont	49
Andover	45
San Diego	42
Nanchang	37
Hebei	34
Ottawa	33
Jiaxing	28
Toronto	28
Guangzhou	27
Shenyang	27
Boardman	25
Changsha	23
Huizen	22
Brussels	21
Tianjin	21
Falls Church	19
Norwalk	18
Kunming	17
Lissone	16
Detroit	15
Hangzhou	14
Mountain View	13
London	11
Dong Ket	10
Helsinki	9
Jinan	9
University Park	9
Auburn Hills	8
Los Angeles	8
Redmond	8
Chicago	7
Edmonton	7
Lanzhou	7
Leawood	7
Kiev	6
Sacramento	6
San Mateo	6
Florence	5
Fuzhou	5
Hefei	5
Kraków	5
Taizhou	5
Torre Del Greco	5
Brescia	4
Changchun	4
Dallas	4
Ningbo	4
Rome	4
Zanjan	4
Zhengzhou	4
Castelleone	3
Central	3
Cormano	3
Grottaglie	3
Henderson	3
Istanbul	3
Kocaeli	3
Loreto	3
Moscow	3
Padova	3
Perugia	3
Shanghai	3
Taipei	3
Wuhan	3
Aci Catena	2
Ardea	2
Bangalore	2
Belgrade	2
Carate Brianza	2
Carugate	2
Castelnuovo Rangone	2
Cermenate	2
Chengdu	2
Como	2
Daejeon	2
Fasano	2
Genova	2
Groningen	2
Haikou	2
Totale	8963

Salva come PNG Salva come JPEG

Nome	#
High-dose epirubicin in patients with advanced or recurrent uterine sarcoma	425
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery	309
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms	255
Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential	219
Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas	217
Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study	205
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer	178
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial	177
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach	170
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers	164
Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study	158
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer	157
Early and short-term complications after US-guided puncture of gynecologic lesions: evaluation after 1,000 consecutive cases	148
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group	146
Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production	145
Pre-operative morphological and colour Doppler features of borderline ovarian tumours	145
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology	143
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer	142
Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors	140
Uterine leiomyosarcoma: analysis of treatment failures and survival	139
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale	138
External validation of diagnostic models to estimate the risk of malignancy in adnexal masses	138
Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection	138
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study	136
Prospective multicenter study on the clinical utility of ca-72.4 in postmenopausal patients with pelvic mass	132
Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale	128
Prospective multicenter study on CA 125 in postmenopausal pelvic masses	128
Role of puncture and aspiration in expectant management of simple ovarian cysts: a randomised study	124
Brachytherapy for isolated vaginal recurrences from endometrial carcinoma	124
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies	120
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy	119
Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial	119
Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cells	118
Endometrial stromal sarcoma: analysis of treatment failures and survival	118
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help	118
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy	117
Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas	116
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma	116
Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer: Validity of pathological response as surrogate endpoint of survival	115
Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma	114
Synchronous early-stage endometrial and ovarian cancer	113
Antiemetic efficacy of granisetron in patients with gynecological malignancies	113
Optimal treatment of early-stage ovarian cancer	113
Safety of transvaginal fine needle puncture of gynecologic masses: a report after 500 consecutive procedures	111
Ovarian cancer prediction in adnexal masses using ultrasound based logistic regression models: a temporal and external validation study by the IOTA group	110
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study	110
Ultrasound in the follow-up of young patients with malignant ovarian tumors after conservative surgery	108
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis	106
Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses	105
Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients	105
Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response	104
Color Doppler ultrasound in the preoperative assessment of adnexal masses	102
Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994	99
Endometriomas: Their ultrasound characteristics	97
Imaging in gynecological disease (7): clinical and ultrasound features of Brenner tumors of the ovary	96
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis	95
International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer	93
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes	92
Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study	92
Primary carcinoma of the fallopian tube. A retrospective analysis of 47 patients	92
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study	92
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer	91
Effectiveness of autologous blood transfusion in patients undergoing radical hysterectomy	91
Second-look laparotomy in the management of fallopian tube carcinoma	91
Ultrasound characteristics of endometrial hyperplasia described using IETA terms	91
Clinically oriented three-step strategy to the assessment of adnexal pathology	90
Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review	87
Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma	87
Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study	85
A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study	85
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients	85
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients	84
Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells	83
The prognostic relevance of histological type in uterine sarcomas: A cooperation task force (CTF) multivariate analysis of 249 cases	81
Ifosfamide in the treatment of malignant epithelial ovarian tumors	78
Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice	78
Alpha-fetoprotein in the management of germ cell tumors of the ovary	76
Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK)	75
Detection of abnormal intrauterine vascularization by color Doppler imaging: A possible additional aid for the follow up of patients with gestational trophoblastic tumors	75
Unilocular adnexal cysts with papillary projections but no other solid components: is there a diagnostic method that can reliably classify them as benign or malignant before surgery?	75
Tumor volume as risk factor for nodal diffusion in endometrial cancer	75
Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel	71
Brain metastases from endometrial carcinoma	70
Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis	67
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial	67
Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer	66
Fertility-sparing surgery in uterine leiomyosarcoma	66
Comparison of methods for monitoring young women with stage I borderline ovarian tumor after conservative surgery	64
Neoplasie dell’apparato genitale femminile	63
Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer	62
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel	62
DeltaNp63 expression is associated with poor survival in ovarian cancer	60
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer	60
Surgical resection of solitary brain metastasis from ovarian carcinoma: an analysis of 22 cases	59
Total neuropathy scale items as early predictors of chemotherapy‐induced peripheral neurotoxicity	58
A prospective study of the role of ultrasound in the management of adnexal masses in pregnancy	57
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial	56
Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses	56
Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females	54
Ultrasound-guided aspiration of endometriomas: possible applications and limitations	49
Totale	11236

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	19446
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	19446

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2017/2018	66	0	0	0	0	0	0	0	0	8	19	19	20
2018/2019	1056	20	12	14	7	21	128	65	58	58	129	296	248
2019/2020	2771	341	165	218	246	268	335	369	191	286	119	187	46
2020/2021	1878	124	82	178	186	122	153	192	179	195	208	104	155
2021/2022	1170	74	89	81	112	105	94	51	90	56	85	103	230
2022/2023	1826	252	573	133	137	181	295	30	98	127	0	0	0
Totale													11510

Bicocca Open Archive

LISSONI, ANDREA ALBERTO

Distribuzione geografica